Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisabetta Bugianesi

Showing results (101-110 of 326) with videos related to

Pageof 33
Sort By:
Journal of Clinical Medicine|August 7, 2021
Switching from Biosimilar to Biosimilar Adalimumab, Including Multiple Switching, in Crohn's Disease: A Prospective StudyDavide Giuseppe Ribaldone, Elisa Tribocco, Chiara Rosso, et al.
Gastroenterology|July 18, 2013
Simple noninvasive systems predict long-term outcomes of patients with nonalcoholic fatty liver diseasePaul Angulo, Elisabetta Bugianesi, Einar S Bjornsson, et al.
Journal of Hepatology|October 7, 2018
An internet-based approach for lifestyle changes in patients with NAFLD: Two-year effects on weight loss and surrogate markersArianna Mazzotti, Maria Turchese Caletti, Lucia Brodosi, et al.
JHEP Reports : Innovation in Hepatology|March 20, 2026
Real-world quality of life and healthcare resource utilization in patients with metabolic dysfunction-associated steatohepatitisJens Marquardt, Riku Ota, Giada Sebastiani, et al.
Acta Diabetologica|May 17, 2011
HBV and HCV infection in type 2 diabetes mellitus: a survey in three diabetes units in different Italian areasValentina Soverini, Marcello Persico, Elisabetta Bugianesi, et al.
Acta Diabetologica|July 31, 2017
Erratum to: HBV and HCV infection in type 2 diabetes mellitus: a survey in three diabetes units in different Italian areasValentina Soverini, Marcello Persico, Elisabetta Bugianesi, et al.
Plos One|September 21, 2016
Renin-Angiotensin System Inhibitors, Type 2 Diabetes and Fibrosis Progression: An Observational Study in Patients with Nonalcoholic Fatty Liver DiseaseSerena Pelusi, Salvatore Petta, Chiara Rosso, et al.
Journal of Clinical Medicine|August 7, 2021
Risk Factors of Urothelial Cancer in Inflammatory Bowel DiseaseGian Paolo Caviglia, Giorgio Martini, Angelo Armandi, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 22, 2019
Myostatin regulates the fibrogenic phenotype of hepatic stellate cells via c-jun N-terminal kinase activationWanda Delogu, Alessandra Caligiuri, Angela Provenzano, et al.
Nutrients|July 14, 2023
Impact of Health Related QoL and Mediterranean Diet on Liver Fibrosis in Patients with NAFLDNuria Perez-Diaz-Del-Campo, Gabriele Castelnuovo, Chiara Rosso, et al.
Pageof 33

Showing results (101-110 of 326) with videos related to

Sort By:
Pageof 33
Journal of Clinical Medicine|August 7, 2021
Switching from Biosimilar to Biosimilar Adalimumab, Including Multiple Switching, in Crohn's Disease: A Prospective StudyDavide Giuseppe Ribaldone, Elisa Tribocco, Chiara Rosso, et al.
Gastroenterology|July 18, 2013
Simple noninvasive systems predict long-term outcomes of patients with nonalcoholic fatty liver diseasePaul Angulo, Elisabetta Bugianesi, Einar S Bjornsson, et al.
Journal of Hepatology|October 7, 2018
An internet-based approach for lifestyle changes in patients with NAFLD: Two-year effects on weight loss and surrogate markersArianna Mazzotti, Maria Turchese Caletti, Lucia Brodosi, et al.
JHEP Reports : Innovation in Hepatology|March 20, 2026
Real-world quality of life and healthcare resource utilization in patients with metabolic dysfunction-associated steatohepatitisJens Marquardt, Riku Ota, Giada Sebastiani, et al.
Acta Diabetologica|May 17, 2011
HBV and HCV infection in type 2 diabetes mellitus: a survey in three diabetes units in different Italian areasValentina Soverini, Marcello Persico, Elisabetta Bugianesi, et al.
Acta Diabetologica|July 31, 2017
Erratum to: HBV and HCV infection in type 2 diabetes mellitus: a survey in three diabetes units in different Italian areasValentina Soverini, Marcello Persico, Elisabetta Bugianesi, et al.
Plos One|September 21, 2016
Renin-Angiotensin System Inhibitors, Type 2 Diabetes and Fibrosis Progression: An Observational Study in Patients with Nonalcoholic Fatty Liver DiseaseSerena Pelusi, Salvatore Petta, Chiara Rosso, et al.
Journal of Clinical Medicine|August 7, 2021
Risk Factors of Urothelial Cancer in Inflammatory Bowel DiseaseGian Paolo Caviglia, Giorgio Martini, Angelo Armandi, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 22, 2019
Myostatin regulates the fibrogenic phenotype of hepatic stellate cells via c-jun N-terminal kinase activationWanda Delogu, Alessandra Caligiuri, Angela Provenzano, et al.
Nutrients|July 14, 2023
Impact of Health Related QoL and Mediterranean Diet on Liver Fibrosis in Patients with NAFLDNuria Perez-Diaz-Del-Campo, Gabriele Castelnuovo, Chiara Rosso, et al.
Pageof 33